What is chronic or persistent diabetic macular edema and how should it be treated?

JAMA Ophthalmology

Volumn 134, Issue 3, 2016, Pages 285-286

  Apte, Rajendra S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; RANIBIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR;

CHRONIC DIABETIC MACULAR EDEMA; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; HUMAN; LASER COAGULATION; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PERSISTENT DIABETIC MACULAR EDEMA; PRIORITY JOURNAL; VISUAL IMPAIRMENT; DIABETIC RETINOPATHY; DRUG EFFECTS; FEMALE; MACULAR EDEMA; MALE; PATHOLOGY; RETINA; VISION DISORDERS; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; RANIBIZUMAB; RETINA; VISION DISORDERS; VISUAL ACUITY;

EID: 84962381533     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2015.5469     Document Type: Note

References (7)

1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985; 103(12): 1796-1806.
2. Boyer DS, Yoon YH, Belfort R Jr, et al.; Ozurdex MEAD Study Group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014; 121(10): 1904-1914.
3. Campochiaro PA, Brown DM, Pearson A, et al.; FAME Study Group. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology. 2011; 118(4): 626-635.e2.
4. Elman MJ, Aiello LP, Beck RW, et al.; Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010; 117(6): 1064-1077.e35.
5. Wells JA, Glassman AR, Ayala AR, et al.; Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015; 372(13): 1193-1203.
6. Bressler SB, Ayala AR, Bressler NM, et al. Persistent macular thickening after ranibizumab treatment for diabetic macular edema with vision impairment [published online January 7, 2016]. JAMA Ophthalmol. doi: 10.1001/jamaophthalmol.2015.5346.
7. Nguyen QD, Brown DM, Marcus DM, et al.; RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012; 119(4): 789-801.